Evaluation of a novel combination of TRAM-34 and ascorbic acid for the treatment of corneal fibrosis in vivo is a research paper published in PLoS ONE (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Eye Institute
Grant: R01EY030774 and U01EY031650
U.S. Department of Veterans Affairs
Grant: 1I01BX00357 and IK6BX005646
BLRD VA
Grant: I01 BX000357
BLRD VA
Grant: IK6 BX005646
NEI NIH HHS
Grant: R01 EY030774
NEI NIH HHS
Grant: U01 EY031650
National Institutes of Health
Grant: 5U01EY031650-02
Turbo Eye Drops to Treat Ocular Toxicity and Blindness from Sulfur Mustard
National Institutes of Health
Grant: 5R01EY030774-03
Novel approaches for corneal haze/fibrosis elimination
National Institutes of Health
Grant: 1IK6BX005646-01
BLR&D Research Career Scientist Award Application (Renewal)
University of Missouri Ruth M. Kraeuchi Missouri Endowed Chair Ophthalmology fund
American College of Veterinary Ophthalmologists Vision for Animals Foundation
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals